Chin Lee
Chief Tech/Sci/R&D Officer bei ALLAKOS INC.
Vermögen: 417 060 $ am 31.03.2024
Aktive Positionen von Chin Lee
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALLAKOS INC. | Chief Tech/Sci/R&D Officer | - | - |
Karriereverlauf von Chin Lee
Ehemalige bekannte Positionen von Chin Lee
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Abbott Biotech, Inc. | Corporate Officer/Principal | - | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - | - |
THERAVANCE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | - | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
CONNECT BIOPHARMA HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 01.03.2022 | - |
Ausbildung von Chin Lee
Northwestern University | Graduate Degree |
The University of North Carolina at Chapel Hill | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
China | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
ALLAKOS INC. | Health Technology |
THERAVANCE BIOPHARMA, INC. | Health Technology |
CONNECT BIOPHARMA HOLDINGS LIMITED | Health Technology |
Private Unternehmen | 2 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Abbott Biotech, Inc. |